As of 10:33 AM on the 15th, Celltrion Healthcare is trading at 95,200 KRW, up 0.95% from the previous day. This marks an 18.85% increase compared to April 20. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.

Today, foreigners have a net sell of 20,000 shares of Celltrion Healthcare, while institutions have a net buy of 5,000 shares, according to provisional data. Over the past five days, individual investors have net sold 1,065,272 shares, whereas foreigners and institutions have net bought 292,625 shares and 779,246 shares, respectively.

On May 8, Celltrion Healthcare was a market highlight for its "strength due to expansion of the immune therapy product sales network in Europe."



[Table] Net Trading Volume of Foreigners and Institutions (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing